NlpI facilitates deposition of C4bp on Escherichia coli by blocking classical complement-mediated killing, which

Yu-ting Tseng1, Shainn-Wei Wang, Kwang Sik Kim

  • 1Institute of Molecular Medicine, National Cheng Kung University Medical College, Tainan City, Taiwan.

Insights

Neonatal meningitis Escherichia coli (NMEC) uses the NlpI protein to cause high bacteremia and evade immune responses. NlpI may be a therapeutic target for E. coli meningitis.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Background:

  • Neonatal meningitis Escherichia coli (NMEC) is a common cause of bacterial meningitis in newborns.
  • NMEC pathogenesis involves high bacteremia and crossing the blood-brain barrier (BBB).
  • Previous work identified the outer membrane protein NlpI's role in NMEC invasion of brain endothelial cells.

Purpose of the Study:

  • To investigate the role of NlpI in NMEC pathogenesis.
  • To determine NlpI's involvement in bacteremia and immune evasion.

Main Methods:

  • Investigated NlpI's role in inducing bacteremia.
  • Assessed NlpI's contribution to evading serum killing via the complement system.
  • Explored potential interactions between NlpI, C4bp, and OmpA.

Main Results:

  • NlpI was shown to be involved in inducing high-level bacteremia.
  • NlpI facilitates evasion of serum killing by recruiting C4bp, a complement regulator.
  • NlpI may mediate the interaction between C4bp and the outer membrane protein OmpA.

Conclusions:

  • NlpI plays a significant role in two key NMEC pathogenesis processes: bacteremia and immune evasion.
  • NlpI represents a potential therapeutic target for preventing and treating E. coli meningitis.

Related Concept Videos

Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...